HCW Biologics Inc.

NASDAQ: HCWB · Real-Time Price · USD
4.15
-0.19 (-4.38%)
At close: Aug 15, 2025, 3:59 PM
4.25
2.38%
After-hours: Aug 15, 2025, 07:39 PM EDT

HCW Biologics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
1.45M 2.57M 3.5M 3.92M 3.93M 2.84M 2.86M 3.82M 3.65M 6.72M 5.38M 3.57M 3.12M n/a 4.1M 4.1M 4.1M
Cost of Revenue
1.1M 1.85M 2.88M 3.22M 3.28M 2.56M 2.28M 3.05M 2.84M 4.14M 3.16M 1.83M 1.71M 543.6K 448.01K 323.9K 158.81K
Gross Profit
345.67K 715.9K 615.04K 704.53K 644.52K 285.81K 576.02K 763.05K 809.44K 2.59M 2.22M 1.74M 1.4M -543.6K 3.65M 3.78M 3.94M
Operating Income
-23.95M -29.48M -37.09M -38.48M -27.85M -25.72M -20.62M -19.56M -18.56M -15.08M -12.52M -12.6M -11.84M -13.37M -8.19M -6.81M -6.84M
Interest Income
n/a n/a n/a n/a n/a n/a 248.5K 248.5K 249.01K 249.01K 516.00 516.00 631.00 568.81K 568.81K 568.81K 569.7K
Pretax Income
-24.75M -30.02M -37.33M -38.37M -27.39M -24.99M -19.73M -18.71M -17.91M -14.9M -12.66M -12.84M -12.08M -12.86M -7.63M -6.24M -6.27M
Net Income
-24.75M -30.02M -37.33M -38.37M -27.39M -24.99M -19.66M -18.64M -17.84M -15M -12.83M -13.01M -12.25M -12.86M -7.63M -6.24M -6.27M
Selling & General & Admin
18.29M 22.07M 29.25M 30.15M 21.09M 18.13M 12.53M 10.7M 9.45M 8.24M 6.82M 6.48M 5.81M 4.98M 3.96M 3.15M 2.79M
Research & Development
5.65M 6.12M 7.3M 7.78M 7.37M 7.68M 8.47M 9.45M 9.8M 9.34M 7.89M 7.93M 7.63M 8.17M 8.1M 7.51M 7.91M
Other Expenses
2.12M 2.14M 1.48M 1.71M 648.21K 691.82K 605.58K 370.83K 86.15K 52.55K -110.11K -65.29K -21.15K 9.89K 232.78K 244.71K 240.3K
Operating Expenses
25.21M 29.36M 37.7M 39.18M 28.49M 26M 21.19M 20.32M 19.37M 17.67M 14.84M 14.55M 13.63M 13.37M 12.29M 10.91M 10.94M
Interest Expense
375.31K 631.14K 383.03K 255.18K 191.03K 284.47K 305.67K 242.34K 147.34K 230.3K 209.1K 179.45K 178.94K 2.54K 2.54K 374.00 374.00
Selling & Marketing Expenses
164.99K 231.16K 5.28M 5.21M 5.12M 5.05M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
27.14M 32.05M 40.58M 42.4M 31.78M 28.56M 23.48M 23.37M 22.2M 21.8M 17.9M 16.17M 14.95M 13.37M 12.29M 10.91M 10.94M
Income Tax Expense
n/a n/a n/a n/a n/a n/a -72.61K -72.61K -73.13K 103.27K 175.88K 175.88K 176.4K n/a n/a n/a n/a
Shares Outstanding (Basic)
44.68M 38.79M 37.82M 37.82M 37.22M 36M 35.93M 35.91M 35.88M 35.86M 35.84M 35.81M 35.78M 29.57M 29.57M 34.25M 34.25M
Shares Outstanding (Diluted)
44.68M 38.79M 37.82M 37.82M 37.22M 36M 35.93M 35.91M 35.88M 35.86M 35.84M 35.81M 35.78M 29.57M 29.57M 34.25M 34.25M
EPS (Basic)
-0.63 -0.78 -1 -1.04 -0.76 -0.7 -0.55 -0.52 -0.5 -0.42 -0.38 -0.41 -0.39 -0.41 -0.23 -0.19 -0.2
EPS (Diluted)
-0.63 -0.78 -1 -1.04 -0.76 -0.7 -0.55 -0.52 -0.5 -0.42 -0.38 -0.41 -0.39 -0.41 -0.23 -0.19 -0.2
EBITDA
-22.95M -28.21M -36.17M -37.19M -26.12M -23.57M -18.45M -17.64M -17.08M -14.31M -12.04M -12.26M -11.5M -12.84M -7.62M -6.23M -6.26M
EBIT
-21.92M -29.39M -36.95M -38.11M -27.2M -24.71M -19.45M -18.52M -17.82M -14.9M -12.59M -12.77M -12.01M -13.37M -8.19M -6.81M -6.84M
Depreciation & Amortization
940.89K 1.18M 776.43K 925.44K 1.08M 1.14M 993.55K 880.42K 745.67K 589.61K 552.28K 512.06K 527.58K 543.6K 611.7K 613.8K 606.81K